U.S. Wireless Telecom Stock News

NasdaqGS:AEBI
NasdaqGS:AEBIMachinery

Aebi Schmidt Holding (NasdaqGS:AEBI) Margin Squeeze Challenges Bullish Growth Narrative

Aebi Schmidt Holding (NasdaqGS:AEBI) has just posted its FY 2025 numbers with fourth quarter revenue of US$528.4 million and basic EPS of US$0.11, alongside trailing twelve month revenue of about US$1.5 billion and EPS of US$0.17. The company has seen quarterly revenue move from US$262.5 million and EPS of US$0.11 in Q3 2024 to US$471.3 million and EPS of US$0.02 in Q3 2025, before reaching the latest Q4 2025 outcome. This sets up a results season in which investors will be weighing top line...
NYSE:TOL
NYSE:TOLConsumer Durables

Assessing Toll Brothers (TOL) Valuation After The Recent 17% One Month Share Price Decline

What Toll Brothers’ Recent Share Performance Signals for Investors Toll Brothers (TOL) has seen its share price move lower recently, with a 17% decline over the past month and a smaller pullback over the past 3 months. This has prompted investors to reassess the homebuilder’s current valuation. See our latest analysis for Toll Brothers. That recent 17% 1 month share price decline comes after a much stronger run, with the latest move easing some of the momentum that previously delivered a...
NYSE:XYZ
NYSE:XYZDiversified Financial

New Commerce Wins And Lending Jitters Might Change The Case For Investing In Block (SQ)

In recent weeks, Block’s Square business has been selected as the unified commerce platform for The Pancake Parlour’s 13 Australian restaurants, reengaged by Cinnaholic to support 85 US franchise locations, and integrated with eGrowcery to power ecommerce and payments for specialty retailer The Fish Guy. At the same time, stress in a private-credit fund holding loans from Block has highlighted investor focus on the risks tied to Block-linked consumer and small-business lending, even as...
NYSE:WAT
NYSE:WATLife Sciences

Is Waters (WAT) Quietly Rewriting Its Capital Playbook With New Shelf Filing And Instrument Launch?

In March 2026, Waters Corporation filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, stock purchase contracts, and units, while also expanding its TA Instruments portfolio with the launch of the next-generation ARES-G3 Rheometer. These moves underscore Waters’ twin focus on maintaining financial flexibility for future capital needs and deepening its presence in high-performance analytical instruments that streamline complex lab...
NYSEAM:GORO
NYSEAM:GOROMetals and Mining

Gold Resource (GORO) Q4 Profit Swing Challenges Bearish Loss-Making Narrative

Gold Resource (GORO) FY 2025 earnings snapshot Gold Resource (GORO) closed out FY 2025 with Q4 total revenue of US$51.3 million and basic EPS of US$0.11. On a trailing 12 month basis the company remained loss making with basic EPS at a US$0.05 loss on net income of a US$6.5 million loss. Over recent periods, total revenue has ranged from US$11.2 million to US$51.3 million a quarter, while quarterly basic EPS has swung between US$0.11 and a US$0.09 loss. This gives investors a clear look at...
NYSE:TME
NYSE:TMEEntertainment

A Look At Tencent Music (TME) Valuation After Recent Share Price Weakness

Recent performance snapshot Tencent Music Entertainment Group (TME) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. For context, Tencent Music Entertainment Group reports revenue of CN¥32,902 and net income of CN¥11,056. The business is focused on music streaming, online karaoke, and live streaming services across its QQ Music, Kugou Music, Kuwo Music, and WeSing...
NYSE:ALLE
NYSE:ALLEBuilding

Reassessing Allegion (ALLE) After A 19% Pullback And Mixed Valuation Signals

Wondering if Allegion at around US$144.66 is offering fair value or a margin of safety right now? This article walks through the key valuation signals that can help you decide. The stock has seen a 1.4% decline over the last 7 days and a 19.4% decline over the last 30 days, even though the 1 year return sits at 14.0% and the 3 year return at 45.5%. These moves come as Allegion continues to feature in broader discussions around building products and security solutions, which keeps it on the...
NYSE:WK
NYSE:WKSoftware

Assessing Workiva (WK) Valuation After A 31% One Year Total Shareholder Return Decline

What recent performance says about Workiva Workiva (WK) has drawn attention after a weak stretch for the stock, with a return of about a 30% decline over the past 3 months and roughly a 31% decline over the past year. See our latest analysis for Workiva. At a share price of $61.68, Workiva’s recent momentum has been soft, with the 90 day share price return of around 30% decline contributing to a 1 year total shareholder return of roughly 31% decline, which signals fading enthusiasm compared...
NYSE:MS
NYSE:MSCapital Markets

Do Morgan Stanley’s (MS) Private Credit Withdrawal Limits Reveal a Deeper Liquidity Strategy Shift?

Morgan Stanley recently restricted investor withdrawals from its North Haven Private Income Fund after redemption requests approached 11% of shares, while also raising fresh fixed-income funding through several callable senior note offerings across 2030, 2032, 2047 and 2028 maturities. These withdrawal limits, introduced alongside similar measures at peers and backed by new bond issuance, highlight how private credit liquidity management has become a central focus for large asset...
NasdaqCM:DVLT
NasdaqCM:DVLTSemiconductor

Why Datavault AI (DVLT) Is Up 30.5% After Surging 2025 Revenue And Wider Net Loss

Datavault AI Inc. has reported its full-year 2025 results, with revenue of US$39.09 million versus US$2.67 million a year earlier and a net loss of US$78.99 million compared with US$51.41 million, alongside basic and diluted loss per share from continuing operations of US$0.52 versus US$16.14 previously. Beyond the headline numbers, the earnings release caps a period of heightened attention on Datavault AI’s Tokenized Legacy platform and ADIO audio technology, which have been highlighted at...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron’s Record Quarter Tests Valuation As AI Capacity Plans Accelerate

Micron Technology (NasdaqGS:MU) reported record fiscal Q2 revenue and profit. The company raised its quarterly dividend by 30% and guided for strong Q3 performance. Micron signed its first five year Strategic Customer Agreement, aimed at longer term supply visibility. The company also announced a major ramp in capital expenditures to expand AI focused memory manufacturing capacity. Micron is a key supplier of memory and storage chips used in data centers, PCs and mobile devices, and is now...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Do AGNC’s Reaffirmed Dividends Hint at a Durable Income Model or Heightened Risk Balance for AGNC (AGNC)?

AGNC Investment Corp. previously announced that its Board of Directors declared a US$0.12 per-share cash dividend for March 2026, payable on April 10, 2026 to common stockholders of record as of March 31, 2026. The simultaneous declaration of quarterly dividends across multiple preferred series, with varying fixed-to-floating and fixed reset structures, underscores AGNC’s emphasis on maintaining consistent income for both common and preferred shareholders. We’ll now examine how reaffirming...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GlobalFoundries Targets AI Data Centers With Silicon Photonics Push

GlobalFoundries (NasdaqGS:GFS) is expanding into silicon photonics, working with Flexcompute to link photonic device design tools directly to its manufacturing stack. The collaboration focuses on optical interconnects for AI data centers, aiming to streamline the path from simulation to fabrication. This move targets a growing market in data center optics while seeking to lower design and integration hurdles for customers. GLOBALFOUNDRIES, trading at $42.47, is drawing attention in advanced...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Is It Too Late To Consider Definium Therapeutics (DFTX) After A 163% One Year Surge?

Considering whether Definium Therapeutics at around US$17.64 still offers value, or if most of the opportunity is already priced in. The stock has seen a 5.3% decline over the last 7 days, but sits on gains of 12.0% over 30 days, 29.3% year to date and 163.3% over 1 year, with a very large 3 year return that is more than 5x, although the 5 year return is a 54.3% decline. Recent market attention has been shaped by broader interest in high growth pharmaceutical and biotech names, where...
NYSE:CI
NYSE:CIHealthcare

Did Bernstein’s PBM-Focused Upgrade Just Shift Cigna Group’s (CI) Investment Narrative?

On March 12, 2026, analysts at Bernstein upgraded The Cigna Group to “Outperform,” citing the impact of PBM reform, an FTC settlement, and changes to the company’s pharmacy benefit model on investor perception. This shift in analyst stance highlights how regulatory outcomes and PBM model adjustments can influence expectations around Cigna’s health services business mix and risk profile. Next, we’ll explore how Bernstein’s upgrade, rooted in PBM reform and regulatory developments, may reshape...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Artisan Partners Backs Bruker As Acquisitions And Pipeline Face Market Headwinds

Artisan Partners has taken a new small cap position in Bruker (NasdaqGS:BRKR), citing confidence in the company’s acquisitions and product pipeline. The investment thesis points to anticipated easing of short term market headwinds as a support for future profit growth. Bruker’s share price stands at $34.03 after a period of pressure, with the stock down 7.6% over the past week and 6.8% over the past month. The drawdown is more extended over longer periods, with a 29.3% decline year to date...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Why Capricor Therapeutics (CAPR) Is Down 8.0% After FDA Resumes Deramiocel Review And Phase 3 Update

Earlier this month, Capricor Therapeutics reported Q4 2025 and full-year results showing a wider net loss of US$30.17 million for the quarter and US$105.04 million for the year, alongside continued investment in its Duchenne muscular dystrophy pipeline. A key development was new Phase 3 HOPE-3 data and the FDA’s decision to resume review of Deramiocel’s Biologics License Application, setting an August 22, 2026 action date for a potential decision on treating Duchenne cardiomyopathy. With the...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

A Look At TTM Technologies (TTMI) Valuation After A Strong Year Of Share Price Momentum

Why TTM Technologies (TTMI) Is On Investors’ Radar Today TTM Technologies (TTMI) is drawing attention after recent share price moves, with the stock showing varied short term returns and a stronger performance over the past year that may prompt closer portfolio review. See our latest analysis for TTM Technologies. The latest share price of $95.31 comes after a 42.06% 90 day share price return and a very large 1 year total shareholder return. Together, these indicate strong recent momentum...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies Shifts Toward AI Modules And Automotive Display Growth

Himax Technologies (NasdaqGS:HIMX) highlighted new AI powered modules and automotive display ICs at Embedded World 2026. The company showcased WiseEye, WiseGuard and PalmVein ultralow power AI solutions for smart home, security, automotive and drone uses. Rumors point to potential collaborations with major tech firms for smart glasses integration and AI data center applications. For you as an investor, this matters because Himax Technologies, long known for display driver ICs, is now...
NYSE:PPL
NYSE:PPLElectric Utilities

Assessing PPL’s Valuation After Earnings Update And US$23b Infrastructure Investment Plan

Event driven move in PPL stock PPL (PPL) is back in focus after the company reported 2025 results, issued a 2026 EPS growth forecast, extended its annual EPS growth target through at least 2029, and outlined a US$23b infrastructure investment plan. See our latest analysis for PPL. At a share price of US$38.05, PPL has had a 9.5% 90 day share price return and a 12.2% 1 year total shareholder return, suggesting momentum has been building alongside its latest results and infrastructure plan. If...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Is It Time To Reassess Sanmina (SANM) After Its Strong Multi Year Share Price Run?

Wondering if Sanmina's share price really reflects its underlying value, or if the recent run in the stock has left mispricing on the table. The stock closed at US$125.03, with returns of 59.8% over 1 year and 118.1% over 3 years, even as the share price has seen a 14.3% drop over 30 days and a 21.5% fall year to date. Recent coverage has focused on Sanmina's role in technology manufacturing and its positioning within the broader electronics supply chain, giving investors more information to...
NYSE:CXT
NYSE:CXTElectronic

Crane NXT Board Shift Brings New Tech Focus To Undervalued Shares

Crane NXT (NYSE:CXT) has appointed technology and manufacturing executive Jeffrey Benck to its Board of Directors. Longtime director James L.L. Tullis will step down from the board after the upcoming Annual Meeting. The board change introduces new industry experience and marks the end of a lengthy period of service by Tullis. For investors tracking Crane NXT, the board shift comes at a time when the share price stands at $41.37, with the stock showing a 21.6% decline over the past 30 days...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Is Goosehead (GSHD) Using ESOP Shares to Sharpen Alignment or Dilute Its Investment Story?

In March 2026, Goosehead Insurance, Inc. filed a shelf registration for up to US$66.65 million, covering 1,510,000 common shares in an employee stock ownership plan (ESOP)-related offering. This ESOP-linked shelf registration highlights Goosehead’s emphasis on employee ownership, which can influence incentives, capital structure, and longer-term business alignment. We’ll now examine how this ESOP-related shelf registration could influence Goosehead Insurance’s investment narrative and its...
NYSE:MAIN
NYSE:MAINCapital Markets

How Main Street Capital’s US$61.5 Million Steel Deal Could Shape MAIN’s Risk Reward Profile

Main Street Capital recently completed a US$61.5 million portfolio investment to support the minority recapitalization of a specialized structural steel fabricator, combining first-lien senior secured term debt, a direct minority equity stake, and a revolving credit facility for future initiatives and working capital. Management also reported record return on equity and growth in net asset value for the latest quarter, underscoring how its blended debt-and-equity approach is shaping the...